Concepedia

Stuart C. Helfand

SC

Statistics

Publications

44

Citations

2.4K

H-Index

28

Active since

1987

Affiliations

University of Wisconsin–Madison(Current)

Oregon State University

University of Pennsylvania

University of Florida

University of Colorado Denver

Stuart C. Helfand is an author at University of Wisconsin–Madison specializing in oncology, medicine, and immunology.

ORCID

Publications per year

1987–2021

44

Publications

44

Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit

Cheryl A. London, Stephen J. Galli, Toshifumi Yuuki et al. · Experimental Hematology · 1999 · 250 citations

, , +16

Evaluation of Prognostic Factors and Sequential Combination Chemotherapy With Doxorubicin for Canine Lymphoma

Evan T. Keller, E. Gregory MacEwen, Robert Rosenthal et al. · Journal of Veterinary Internal Medicine · 1993 · 217 citations

, , +13

Chemotherapy of Canine Hemangiosarcoma With Doxorubicin and Cyclophosphamide

Karin U. Sørenmo, K. Ann Jeglum, Stuart C. Helfand · Journal of Veterinary Internal Medicine · 1993 · 145 citations

, , +17

Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.

Ilene D. Kurzman, E. Gregory MacEwen, Robert Rosenthal et al. · PubMed · 1995 · 142 citations

, , +17

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.

David M. Vail, E. Gregory MacEwen, Ilene D. Kurzman et al. · PubMed · 1995 · 132 citations

, , +17

1–5 of 44